Intra-articular joint injections are widely used in horse pain management, but welfare-conscious use requires balancing effective analgesia with risks of masking underlying pathology and infection risk.
Joint injection welfare ethics center on the distinction between therapeutic pain management and enabling horses to compete with injuries they cannot feel. Responsible joint injection manages pain in a horse that receives appropriate rest and rehabilitation; it becomes welfare-concerning when used to enable horses to continue working or competing despite underlying pathology that should mandate rest. The masking effect of effective analgesia means horses may work through conditions that would naturally limit activity, potentially worsening underlying pathology. Competition regulations in many disciplines prohibit joint injections close to competition dates for this reason - but enforcement is inconsistent and the temptation to enable marginal horses to compete remains. The ideal welfare framework for joint injection is pain management in service of appropriate rehabilitation with clear evidence of pathology resolution before return to full work - not a routine performance enhancement tool.